MedTrace Logo

"resiLIR Healthcare Professionals": A Psychological Online Intervention to Enhance Resilience in Healthcare Professionals

NCT05812716 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 224

Last updated 2024-10-23

No results posted yet for this study

Summary

The goal of this clinical trial is to evaluate an online resilience intervention with healthcare professionals. Participants will receive a 6-week online intervention addressing resilience and stress with a specific focus on self-care and self-compassion. The main question is whether the intervention is effective in increasing resilience.

Conditions

  • Resilience

Interventions

BEHAVIORAL

resiLIR Healthcare Professionals

Weeks 1 and 2: Theoretical part on stress, resilience, self-care, and self-compassion Weeks 3 to 6: Training phase of a weekly introduced practical exercise (reflection on living with ease, self-compassionate body scan, planning of positive activities, self-compassionate letter). This phase additionally includes smartphone reminders to apply the exercises in everyday life.

Sponsors & Collaborators

  • European Regional Development Fund

    collaborator OTHER

  • Ministry of Science and Health of Rhineland-Palatinate, Germany

    collaborator UNKNOWN

  • Fraunhofer Institute for Industrial Mathematics ITWM

    collaborator UNKNOWN

  • Leibniz-Institut für Resilienzforschung (LIR) gGmbH

    lead OTHER

Principal Investigators

  • Oliver Tüscher · Leibniz Institute of Resilience Research

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-06-20
Primary Completion
2024-07-04
Completion
2024-07-04

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05812716 on ClinicalTrials.gov